Form 4 for CYTK CYTOKINETICS INC
Accepted 2025-03-17 00:00:00 ET · period of report 2025-03-17 · accession 0001127602-25-009711 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-17 | 2025-03-17 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale | $44.38 | -4,389 | 101.0K | -4% | -$194.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-17 | S | D | 4,389 | $44.38 | 101,005 | D | — | — |